0001104659-19-020219.txt : 20190405
0001104659-19-020219.hdr.sgml : 20190405
20190405193430
ACCESSION NUMBER: 0001104659-19-020219
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190403
FILED AS OF DATE: 20190405
DATE AS OF CHANGE: 20190405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NISSEN TORBEN STRAIGHT
CENTRAL INDEX KEY: 0001746647
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38586
FILM NUMBER: 19736203
MAIL ADDRESS:
STREET 1: C/O RUBIUS THERAPEUTICS
STREET 2: 325 VASSAR ST., STE. 1A
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rubius Therapeutics, Inc.
CENTRAL INDEX KEY: 0001709401
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042688109
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-679-9600
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET, SUITE 300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
a4.xml
4
X0306
4
2019-04-03
0
0001709401
Rubius Therapeutics, Inc.
RUBY
0001746647
NISSEN TORBEN STRAIGHT
C/O RUBIUS THERAPEUTICS, INC.
399 BINNEY STREET, SUITE 300
CAMBRIDGE
MA
02139
0
1
0
0
President
Common Stock
2019-04-03
4
S
0
500
20.00
D
1859500
D
Common Stock
2019-04-05
4
S
0
12096
20.00
D
1847404
D
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Joanne M. Protano, Attorney-in-Fact
2019-04-05